Total Payments
$4,858
2024 Payments
$1,025
Companies
41
Transactions
261
Medicare Patients
3,582
Medicare Billing
$260,661
Payment Breakdown by Category
Food & Beverage$4,849 (99.8%)
Education$9.41 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,849 | 260 | 99.8% |
| Education | $9.41 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $689.49 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $628.94 | 36 | $0 (2024) |
| Novo Nordisk Inc | $447.95 | 26 | $0 (2024) |
| PFIZER INC. | $419.07 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $349.48 | 22 | $0 (2024) |
| Lilly USA, LLC | $229.15 | 14 | $0 (2024) |
| Amgen Inc. | $224.95 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $224.76 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $165.99 | 3 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $111.90 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,025 | 49 | Novo Nordisk Inc ($207.11) |
| 2023 | $723.89 | 42 | AstraZeneca Pharmaceuticals LP ($166.59) |
| 2022 | $481.14 | 26 | ABBVIE INC. ($229.40) |
| 2021 | $882.59 | 51 | AbbVie Inc. ($251.13) |
| 2020 | $208.07 | 12 | AstraZeneca Pharmaceuticals LP ($59.42) |
| 2019 | $402.00 | 24 | AstraZeneca Pharmaceuticals LP ($173.37) |
| 2018 | $524.22 | 28 | E.R. Squibb & Sons, L.L.C. ($138.02) |
| 2017 | $611.62 | 29 | PFIZER INC. ($273.10) |
All Payment Transactions
261 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $18.59 | General |
| Category: Coronary | ||||||
| 12/04/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Genetic Disease | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.19 | General |
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| Category: Coronary | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Biological | ||||||
| 11/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Endocrinology | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: Coronary | ||||||
| 10/10/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Genetic Disease | ||||||
| 10/05/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $59.91 | General |
| Category: WATCHMAN_IC | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/11/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $44.05 | General |
| Category: WATCHMAN_IC | ||||||
| 09/11/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 09/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Obesity | ||||||
| 08/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Obesity | ||||||
| 08/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 227 | 689 | $229,703 | $49,679 |
| 2022 | 4 | 198 | 733 | $232,994 | $45,560 |
| 2021 | 16 | 3,002 | 3,683 | $479,501 | $136,507 |
| 2020 | 5 | 155 | 482 | $156,740 | $28,916 |
Total Patients
3,582
Total Services
5,587
Medicare Billing
$260,661
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 394 | $122,140 | $23,210 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 158 | $55,300 | $13,628 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 58 | 58 | $21,750 | $7,064 | 32.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 24 | $10,128 | $2,136 | 21.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 18 | $9,180 | $1,744 | 19.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 26 | $5,694 | $955.24 | 16.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $5,511 | $940.94 | 17.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 528 | $163,589 | $28,248 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 135 | $47,250 | $9,837 | 20.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $21,375 | $7,112 | 33.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $780.00 | $363.92 | 46.7% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 1,171 | 1,178 | $70,652 | $34,138 | 48.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 43 | 489 | $151,590 | $26,464 | 17.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 289 | $101,150 | $26,282 | 26.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 1,070 | 1,072 | $54,672 | $20,021 | 36.6% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 247 | 247 | $12,597 | $9,426 | 74.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 53 | 53 | $19,875 | $6,723 | 33.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 54 | 54 | $28,350 | $5,474 | 19.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 40 | $9,000 | $2,543 | 28.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 20 | 20 | $3,000 | $1,305 | 43.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 12 | 43 | $9,417 | $1,258 | 13.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,936 | $810.49 | 20.6% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 31 | 35 | $3,850 | $541.91 | 14.1% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 14 | 14 | $910.00 | $534.24 | 58.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 30 | 30 | $1,800 | $486.60 | 27.0% |
About Dr. Stefanie Ruffolo, M.D
Dr. Stefanie Ruffolo, M.D is a Internal Medicine healthcare provider based in Kenosha, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1548572696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stefanie Ruffolo, M.D has received a total of $4,858 in payments from pharmaceutical and medical device companies, with $1,025 received in 2024. These payments were reported across 261 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($4,849).
As a Medicare-enrolled provider, Ruffolo has provided services to 3,582 Medicare beneficiaries, totaling 5,587 services with total Medicare billing of $260,661. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics, Pediatric Critical Care Medicine
- Location Kenosha, WI
- Active Since 07/06/2010
- Last Updated 02/04/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548572696
Products in Payments
- FARXIGA (Drug) $397.15
- XARELTO (Drug) $349.48
- ELIQUIS (Drug) $312.39
- UBRELVY (Drug) $284.91
- Ozempic (Drug) $211.44
- VRAYLAR (Drug) $197.85
- ENTRESTO (Drug) $154.19
- ZENPEP (Drug) $139.48
- Wegovy (Drug) $121.90
- AIRSUPRA (Drug) $107.89
- CHANTIX (Drug) $105.08
- WATCHMAN Access System (Device) $103.96
- CREON (Drug) $102.03
- EUCRISA (Drug) $100.00
- Repatha (Biological) $98.46
- LINZESS (Drug) $97.93
- Vascepa (Drug) $91.58
- Assure WCD (Device) $89.80
- LifeVest (Device) $76.75
- EMGALITY (Drug) $76.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kenosha
Dr. Hasnain Bawaadam, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $473,003
Internal Medicine $473,003
Alfred Habel, Md, MD
Internal Medicine — Payments: $223,905
Internal Medicine $223,905
Rosanna Ranieri, Md, MD
Internal Medicine — Payments: $64,322
Internal Medicine $64,322
Mario Garretto, Md, MD
Internal Medicine — Payments: $8,717
Internal Medicine $8,717
Dr. Sudip Ringwala, D.o, D.O
Internal Medicine — Payments: $6,114
Internal Medicine $6,114
Dr. Rodrigo Mata, M.d, M.D
Internal Medicine — Payments: $5,201
Internal Medicine $5,201